title: Lupus nephritis: Transatlantic management recommendations compared.
authors.forename: Falk
authors.initials: F
authors.lastname: Hiepe
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005060:Europe; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007391:International Cooperation; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009398:Nephrology / Q000639:trends; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012219:Rheumatology / Q000639:trends; D012955:Societies, Medical; D014481:United States
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D009173:Mycophenolic Acid